Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Long Zhe Guo"'
Publikováno v:
IEEE Internet of Things Journal. 8:12550-12558
Congestive heart failure (CHF) is a chronic heart condition with heart function decline caused by various heart diseases that requires long-term treatment and affects personal life safety. Presently, CHF diagnosis is being conducted by experts, which
Publikováno v:
Clinical & Experimental Thrombosis and Hemostasis. 4:7-10
Autor:
Jong Sung Park, Long Zhe Guo, Victor L. Serebruany, Moo Hyun Kim, Tae Ho Park, Cai De Jin, Michael S. Lee, Young Rak Cho, Eun-Seok Shin, Soe Hee Ann, Kyungil Park
Publikováno v:
International Journal of Cardiology. 222:639-644
The impact of thienopyridine reloading on clinical outcomes, and residual high platelet reactivity (HPR) is unclear. We sought to compare the HRP-related effect of prasugrel and clopidogrel reloading in the already clopidogrel-loaded patients undergo
Autor:
Enze Jin, Eun-Seok Shin, Long Zhe Guo, Moo Hyun Kim, Michael S. Lee, Soo Jin Kim, Jong Sung Park, Cai De Jin, Soe Hee Ann, Young-Rak Cho
Publikováno v:
International journal of cardiology. 305
The CYP2C19*2 or *3 loss-of-function (LOF) allele is associated with high platelet reactivity (HPR) on clopidogrel treatment. East Asians may benefit from a lower dose of prasugrel due to their more potent platelet inhibitory response. The impact of
Autor:
Jae Lim Choi, Jin Yeong Han, Bo-Ram Kim, Shuhua Li, Kwang Sook Woo, Moo Hyun Kim, Long Zhe Guo, Ri Young Goh
Publikováno v:
Annals of Laboratory Medicine
Background An association has been reported between CYP2C19 polymorphism and the altered antiplatelet activity of clopidogrel. We investigated this association using the newly introduced platelet function analyzer (PFA)-200 (INNOVANCE PFA-200 System;
Publikováno v:
Circulation Journal. 80:998-1007
Background Although stem cells have been regarded as a promising therapeutic option, the marginal therapeutic effects of stem cells are limitations that must be overcome for the development of effective cell therapy. This study sought to identify the
Autor:
Kyungil Park, Moo Hyun Kim, Tae Ho Park, Young Dae Kim, Long Zhe Guo, Young Seok Lee, Jong Sung Park, Young-Rak Cho, Cai De Jin
Publikováno v:
Circulation Journal. 79:1248-1254
BACKGROUND There is insufficient data on the efficacy of prasugrel and ticagrelor in Korean patients with ST-segment elevation myocardial infarction (STEMI). METHODS AND RESULTS I n the current double-blind, prospective pilot study, 39 patients with
Publikováno v:
Journal of thrombosis and thrombolysis. 44(4)
Acute myocardial infarction (AMI) is one of the leading causes of morbidity and mortality worldwide, while early diagnosis still represents an upmost priority. While platelet activation is critical for AMI pathogenesis, the role of platelet microRNAs
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 28(1)
Clopidogrel response variability (CRV) is well documented, and may affect clinical outcomes. Impact of genetic polymorphisms is important for assessing and predicting CRV. The extensive evidence indicates the importance of CYP2C19 variants in reducin
Autor:
Jong Seong Park, Sun Young Choi, Victor L. Serebruany, Moo Hyun Kim, Chang Heon Shim, Enze Jin, Tae Hyung Kim, Long Zhe Guo
Publikováno v:
Nephron. 132(3)
Background: Clopidogrel and aspirin combination remains a cornerstone for modern dual antiplatelet therapy (DAPT) following coronary stenting. Although monitoring is not currently recommended, certain high-risk cohorts may benefit from tailoring anti